Intraoperative blood transfusions in highly alloimmunized patients undergoing orthotopic liver transplantation
- PMID: 2655216
- PMCID: PMC3005203
- DOI: 10.1097/00007890-198905000-00010
Intraoperative blood transfusions in highly alloimmunized patients undergoing orthotopic liver transplantation
Abstract
Intraoperative blood requirements were analyzed in patients undergoing primary orthotopic liver transplantation and divided into two groups on the basis of panel reactive antibody of pretransplant serum measured by lymphocytotoxicity testing. One group of highly sensitized patients (n = 25) had PRA values of over 70% and the second group of patients (n = 26) had 0% PRA values and were considered nonsensitized. During the transplant procedure, the 70% PRA group received considerably greater quantities of blood products than the 0% PRA group--namely, red blood cells: 21.1 +/- 3.7 vs. 9.8 +/- 0.8 units (P = 0.002), and platelets: 17.7 +/- 3.2 vs. 7.5 +/- 1.5 units (P = 0.003). Similar differences were observed for fresh frozen plasma and cryoprecipitate. Despite the larger infusion of platelets, the blood platelet counts in the 70% PRA group were lower postoperatively than preoperatively. Twenty patients in the 70% PRA group received platelet transfusions, and their mean platelet count dropped from 95,050 +/- 11,537 preoperatively to 67,750 +/- 8,228 postoperatively (P = 0.028). In contrast, nearly identical preoperative (84,058 +/- 17,297) and postoperative (85,647 +/- 12,445) platelet counts were observed in the 17 0% PRA patients who were transfused intraoperatively with platelets. Prothrombin time, activated partial thromboplastin time, and fibrinogen levels showed no significant differences between both groups. These data demonstrate that lymphocytotoxic antibody screening of liver transplant candidates is useful in identifying patients with increased risk of bleeding problems and who will require large quantities of blood during the transplant operation.
Figures





Similar articles
-
Sensitization.Clin Transpl. 1992:357-69. Clin Transpl. 1992. PMID: 1306712
-
Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study.Blood. 1995 Apr 1;85(7):1736-41. Blood. 1995. PMID: 7703481
-
Relationship of HLA and platelet-reactive antibodies in alloimmunized patients refractory to platelet therapy.Am J Hematol. 1987 Dec;26(4):341-52. doi: 10.1002/ajh.2830260407. Am J Hematol. 1987. PMID: 3687931
-
Rituximab, plasma exchange and intravenous immunoglobulins as a new treatment strategy for severe HLA alloimmune platelet refractoriness.Platelets. 2015;26(2):190-4. doi: 10.3109/09537104.2014.895922. Epub 2014 May 27. Platelets. 2015. PMID: 24867634 Review.
-
Clinical aspects of platelet transfusions.Blood Coagul Fibrinolysis. 1991 Apr;2(2):389-96. doi: 10.1097/00001721-199104000-00026. Blood Coagul Fibrinolysis. 1991. PMID: 1893071 Review.
Cited by
-
Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies.Transpl Immunol. 1994;2(1):61-7. doi: 10.1016/0966-3274(94)90080-9. Transpl Immunol. 1994. PMID: 8081794 Free PMC article.
-
GRG profiles: Professor Ignazio Marino.Dig Dis Sci. 2014 Sep;59(9):2033-5. doi: 10.1007/s10620-014-3301-5. Dig Dis Sci. 2014. PMID: 25142168 No abstract available.
-
Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model.Am J Pathol. 1993 May;142(5):1383-91. Am J Pathol. 1993. PMID: 8494042 Free PMC article.
-
A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies.Hepatology. 1992 Sep;16(3):671-81. doi: 10.1002/hep.1840160310. Hepatology. 1992. PMID: 1505910 Free PMC article.
-
Liver transplantation without the use of blood products.Arch Surg. 1994 May;129(5):528-32; discussion 532-3. doi: 10.1001/archsurg.1994.01420290074011. Arch Surg. 1994. PMID: 8185476 Free PMC article.
References
-
- Calne RY. Management of bleeding. In: Sir Roy Calne, editor. Liver transplantation. 2nd ed. London: Grune & Stratton; 1987. p. 247.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials